MediXall Group, Inc. (OTCMKTS:MDXL) Files An 8-K Changes in Registrant’s Certifying Accountant

MediXall Group, Inc. (OTCMKTS:MDXL) Files An 8-K Changes in Registrant’s Certifying Accountant
Item 4.01. Changes in Registrant’s Certifying Accountant.

Story continues below

On March 1, 2018, the Registrant was informed by Baum & Co., Inc. (“Baum”) that he was resigning and thus terminating its services as the Registrant’s independent registered public accounting firm effective March 1, 2018. We have yet to replace the firm but are conducting interviews now for a replacement.

The Termination of Baum

Baum was the independent registered public accounting firm for the Registrant since inception until March 1, 2018. Baum’s reports on the Registrant’s financial statements for the years ended December 31, 2017 and 2016 did not (a) contain an adverse opinion or disclaimer of opinion, or (b) was modified as to uncertainty, audit scope, or accounting principles, or (c) for the two most recent fiscal years ended December 31, 2017 through the date of resignation, there were no disagreements on any matters of accounting principles of practices, financial statement disclosure, or auditing scope or procedures, which disagreements, if not resolved to the satisfaction of Baum, would have caused it to make reference to the subject matter of the disagreements in connection with its reports. None of the reportable events set forth in Item 304(a)(1)(iv) of Regulation S-K occurred during the period in which Baum served as the Registrant’s principal independent accountants.

The Registrant has provided Baum with a copy of this disclosure and has requested that Baum furnish it with a letter addressed to the U.S. Securities and Exchange Commission stating whether it agrees with the above statements, and if not, stating the respects in which it does not agree. A copy of the letter from Baum addressed to the Securities and Exchange Commission dated March 7, 2018 is filed as Exhibit 16.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits

16.1

Letter from Baum & Company, P.A. dated March 7, 2018 to the Securities and Exchange Commission regarding statements included in this Form 8-K.


MediXall Group, Inc. Exhibit
EX-16.1 2 mdxl_ex16z1.htm AUDITOR LETTER Auditor Letter   EXHIBIT 16.1 Baum & Company,…
To view the full exhibit click here

About MediXall Group, Inc. (OTCMKTS:MDXL)

MediXall Group Inc formely ‘Continental Rail Corp’. is a freight rail transportation holding company. The Company focuses to conduct its operations through two divisions: railroad freight division and rail rolling stock leasing division. The Company’s rail freight division focuses to acquire ancillary and complimentary operations for the short line and regional freight railroad industry. The Company’s rail rolling stock leasing division seeks to purchase existing rail car and locomotive leasing companies and/or directly purchase rolling stock for lease to railroads. The Company’s rail rolling stock leasing division seeks to acquire rail-related service companies to partner with its freight railroad operations. These operations consist of repair facilities, track refurbishing facilities and other complimentary operations. The Company has not generated any revenues.

An ad to help with our costs